• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

NOCD Raises $33M for OCD Treatment Platform & Address Global OCD Crisis

Share:

September 27, 2021

What You Should Know:

–NOCD, a Chicago-based provider of obsessive compulsive-disorder (OCD) treatment raises $33M in Series B funding led by F-Prime Capital, with Eight Roads Ventures, and Kaiser Permanente Ventures participating along with existing investors including 7wireVentures, Health Enterprise Partners (HEP), and Chicago Ventures.

– The funds will be used to expand NOCD’s community, reach people earlier in their treatment journey, and offer additional services to assist with their long-term health.

Effective, affordable & convenient OCD therapy

Community-Driven Therapy leverages condition-specific peer communities to identify consumers in need of help, encourage them to begin treatment, and serve them in a highly personalized way. In the case of NOCD, many people are motivated to start treatment after hearing from others in the NOCD community who have overcome similar, difficult challenges. Additionally, the compelling community data drives NOCD’s clinical leadership team to deliver evidence-based treatment services to community members in highly personalized ways. Data show that the Community-Driven Therapy market is poised to successfully address many severe and costly needs within behavioral health, starting with OCD.

Milestones/Traction to Date

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

With over 18 consecutive months of rapid growth and demonstrated, measurable, and sustainable improved outcomes, NOCD has solidified its position as the global leader in OCD treatment and in Community-Driven Therapy. The company has not only built the world’s largest OCD patient online community – bringing to light a massive, underserved behavioral health population – it has also scaled a widely used online therapy service for its community. Inside the NOCD platform, members can receive ongoing, face-to-face telehealth sessions from licensed NOCD therapists that specifically specialize in OCD treatment. Additionally, members have access to always-on support when their therapist is unavailable, including personalized peer groups and self-help tools. NOCD’s use of sophisticated technology allows it to deliver a high-touch personalized treatment, which turns out to be a perfect fit for a chronic yet manageable condition like OCD. NOCD’s comprehensive treatment model has proven to be a more effective, affordable, and convenient treatment than the current standard of care.

To date, NOCD is now delivering more than 12,000 live telehealth visits per month through the only nationwide network of exposure and response prevention (ERP) specialty-trained providers, with outcomes showing 40% improvement in a patient’s health within as few as 90 days. To make ERP, a once historically unaffordable treatment, more accessible, NOCD has partnered with the nation’s leading health insurance companies, offering more than a third of Americans access to NOCD therapy as a covered benefit.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Australia’s TGA clears TALi’s new attention training device and more briefsAustralia’s TGA clears TALi’s new attention training device and more briefs
  • Blood Bags Market Size Key Opportunity, Application and Forecast to 2027Blood Bags Market Size Key Opportunity, Application and Forecast to 2027
  • Private Healthcare & Diagnostics Market Research Methodology 2021 with Top Manufactures and Market Size Estimate 2026Private Healthcare & Diagnostics Market Research Methodology 2021 with Top Manufactures and Market Size Estimate 2026
  • Where blockchain in healthcare might actually make a differenceWhere blockchain in healthcare might actually make a difference
  • 2022’s Top 5 FDA Drug Approvals are Major Advancements in Cancer, Cardiovascular Disease and Rare Disorders2022’s Top 5 FDA Drug Approvals are Major Advancements in Cancer, Cardiovascular Disease and Rare Disorders
  • Oncternal Therapeutics Merges with GTxOncternal Therapeutics Merges with GTx
  • Mateon and Oncotelic Complete Their Merger and Create a New Immuno-Oncology Company with a Late-Stage Clinical Asset Against Cancer and a Promising Product PipelineMateon and Oncotelic Complete Their Merger and Create a New Immuno-Oncology Company with a Late-Stage Clinical Asset Against Cancer and a Promising Product Pipeline
  • AI is going to transform the pharmaceutical industry. Here’s how.AI is going to transform the pharmaceutical industry. Here’s how.

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications